<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal hematopoietic stem cell diseases </plain></SENT>
<SENT sid="1" pm="."><plain>It has been reported that several <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> are associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, the co-occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 and <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorders</z:e> of the immune system, such as <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD), has been described </plain></SENT>
<SENT sid="3" pm="."><plain>Prognosis in the older-<z:hpo ids='HP_0003674'>onset</z:hpo> group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-associated BD is unfavorable </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we report a case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-associated intestinal BD treated successfully by <z:chebi fb="0" ids="2038">azacitidine</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>A 59-year-old Japanese male suffering from recurrent high <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0002249'>melena</z:hpo>, and oral and <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulcerations</z:e> was diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 and intestinal BD by endoscopic and bone marrow examinations </plain></SENT>
<SENT sid="6" pm="."><plain>Immunosuppressive therapies, including infliximab, were ineffective </plain></SENT>
<SENT sid="7" pm="."><plain>Due to his severe <z:hpo ids='HP_0002097'>emphysema</z:hpo>, the patient was considered ineligible for stem cell transplantation, and <z:chebi fb="0" ids="2038">azacitidine</z:chebi> therapy was initiated </plain></SENT>
<SENT sid="8" pm="."><plain>With the exception of <z:hpo ids='HP_0001945'>fever</z:hpo>, the symptoms of intestinal BD improved, and severe <z:hpo ids='HP_0004395'>malnutrition</z:hpo> and <z:hpo ids='HP_0001903'>anemia</z:hpo> were ameliorated </plain></SENT>
<SENT sid="9" pm="."><plain>Fluorescence in situ hybridization analyses of the bone marrow before the eighth cycle revealed that the <z:mp ids='MP_0004027'>trisomy</z:mp> 8 had not decreased </plain></SENT>
<SENT sid="10" pm="."><plain>To our knowledge, this is the first report of <z:chebi fb="0" ids="2038">azacitidine</z:chebi> therapy for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-associated BD </plain></SENT>
<SENT sid="11" pm="."><plain>We suggest that <z:chebi fb="0" ids="2038">azacitidine</z:chebi> may control intestinal BD by mechanisms other than those responsible for its effect in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>